(Q40771348)

English

Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1 reference

based on heuristic

inferred from title

author name string

Rait AS

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Pirollo KF

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Rait V

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Krygier JE

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Xiang L

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Chang EH

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

728-739

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700359

0 references

The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular and clinical aspects of the Neu/ErbB-2 receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence supporting a signal transduction pathway leading to the radiation-resistant phenotype in human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Boranophosphates support the RNase H cleavage of polyribonucleotides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

p66Shc isoform down-regulated and not required for HER-2/neu signaling pathway in human breast cancer cell lines with HER-2/neu overexpression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of erbB-2-positive breast cancer cell growth by erbB-2 antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast tumor cell lines from pleural effusions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Apoptosis by death factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Bcl-2 family proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of the erbB-2 tyrosine kinase receptor in breast cancer cells by phosphoromonothioate and phosphorodithioate antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

SupraMolecular BioVectors (SMBV) improve antisense inhibition of erbB-2 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisense oligonucleotides specific for the HER2/neu oncogene inhibit the growth of human breast carcinoma cells that overexpress HER2/neu

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

A gain-of-function mutation in Drosophila MAP kinase activates multiple receptor tyrosine kinase signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

A temperature-sensitive MEK mutation demonstrates the conservation of the signaling pathways activated by receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700359

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700359

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40771348&oldid=1906944782"